Atlas Trials

IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine

Clinical trial NCT02664116 · UNKNOWN

Trial details

NCT number
NCT02664116
Sponsor
Scripps Health
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Migraine Headache
Start date
2016-01-01
Primary completion
2017-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.